Efficacy and safety of adjuvant endocrine therapy in premenopausal patients with early‐stage hormone receptor‐positive breast cancer: A meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of adjuvant endocrine therapy in premenopausal patients with early‐stage hormone receptor‐positive breast cancer: A meta‐analysis of randomized controlled trials

Published:2019-07-12 Issue:6 Volume:25 Page:1297-1299
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Wei Fengqin¹,Chen Weiyu²,Lin Xiaoti³^ORCID

Affiliation:

1. Department of Emergency Fujian Provincial 2^nd People's Hospital, Affiliated Hospital of Fujian University of Traditional Chinese Medicine Fuzhou China

2. Department of Physiology, Zhongshan Medical School Sun Yat‐sen University Guangzhou China

3. Department of Breast Fujian Provincial Maternity and Children's Hospital of Fujian Medical University Fuzhou China

Funder

China Postdoctoral Science Foundation

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.13465

Reference8 articles.

1. Challenges in the management of advanced, ER-positive, HER2-negative breast cancer

2. Breast cancer statistics, 2017, racial disparity in mortality by state

3. Female Sexuality in Premenopausal Patients with Breast Cancer on Endocrine Therapy

4. Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

5. Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. XGboost Prediction Model Based on 3.0T Diffusion Kurtosis Imaging Improves the Diagnostic Accuracy of MRI BiRADS 4 Masses;Frontiers in Oncology;2022-03-17